advertisement
Goodkin ML 12
Showing records 1 to 12 |
Display all abstracts from Goodkin ML85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in BrazilBelfort R
Clinical Therapeutics 2020; 42: 263-275
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsCraven ER
Drugs 2020; 80: 167-179
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in BrazilPaula JS
Clinical Therapeutics 2020; 42: 263-275
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsWalters T; Christie WC
Drugs 2020; 80: 167-179
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in BrazilLopes Silva MJ
Clinical Therapeutics 2020; 42: 263-275
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsDay DG
Drugs 2020; 80: 167-179
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in BrazilDella Paolera M; Kim T
Clinical Therapeutics 2020; 42: 263-275
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsLewis RA
Drugs 2020; 80: 167-179
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in BrazilChen MY
Clinical Therapeutics 2020; 42: 263-275
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsGoodkin ML
Drugs 2020; 80: 167-179
85136 Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in BrazilGoodkin ML
Clinical Therapeutics 2020; 42: 263-275
84829 24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma PatientsChen M; Wangsadipura V; Robinson MR; Bejanian M;
Drugs 2020; 80: 167-179
Issue 21-1
Change Issue
advertisement